tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market
Want to see TRAW full AI Analyst Report?

Traws Pharma (TRAW) Income Statement

1,859 Followers

Traws Pharma Income Statement

Last quarter (Q4 2025), Traws Pharma's total revenue was $57.00K, a decrease of -49.56% from the same quarter last year. In Q4, Traws Pharma's net income was $-3.04M. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 2.79M$ 226.00K$ 226.00K$ 226.00K$ 226.00K
Gross Profit
$ 2.73M$ 214.00K$ 226.00K$ 226.00K$ 226.00K
Operating Expenses
$ 20.66M$ 49.56M$ 20.52M$ 19.85M$ 16.72M
Depreciation and Amortization
$ 61.00K$ 12.00K$ 16.00K$ 14.00K$ 14.00K
EBITDA
$ -17.81M$ -166.51M$ -20.28M$ -19.61M$ -16.48M
Operating Income
$ -17.88M$ -49.35M$ -20.30M$ -19.63M$ -16.50M
Other Income/Expenses
$ 27.05M$ -117.17M$ 1.35M$ 663.00K$ 333.00K
Pretax Income
$ 9.17M$ -166.52M$ -18.95M$ -18.96M$ -16.16M
Net Income
$ 9.17M$ -54.67M$ -18.95M$ -18.96M$ -16.16M
Per Share Metrics
Basic EPS
$ 0.83$ -35.21$ -22.57$ -22.68$ -24.01
Diluted EPS
$ 0.82$ -35.21$ -22.57$ -22.68$ -24.01
Weighted Average Shares Outstanding
8.23M 1.55M 839.55K 836.33K 673.29K
Weighted Average Shares Outstanding (Diluted)
8.38M 1.55M 839.55K 836.33K 673.29K
Currency in USD

Traws Pharma Earnings and Revenue History